JPM Webinar

Personalized Medicine in Autism Spectrum Disorder

We are currently in an era of rapid development in precision medicine. The traditional ‘one-size-fits-all’ approach to neurodevelopmental disorders is being replaced by personalized strategies tailored to the unique biological and genetic profiles of each individual. Autism Spectrum Disorder, characterized by its high degree of clinical and genetic heterogeneity, stands as one of the most critical frontiers for this transition.

As we move beyond broad behavioral diagnoses, the integration of multi-omics—including genomics, epigenetics, and metabolic profiling—is profoundly transforming our understanding of ASD. By identifying specific biological subtypes and individualized disease mechanisms, we can move toward earlier detection and more targeted interventions. Whether through pharmacogenetics to optimize medication or personalized behavioral therapies guided by biomarkers, our ultimate goal is to ensure that every individual receives the most effective, life-enhancing support at the earliest possible stage.

For this webinar, we are honored to have invited several distinguished experts in this field, including clinical geneticists, neuroscientists, psychiatrists, and pediatricians. They will share the latest basic research findings, clinical translational results, and cutting-edge academic perspectives focused on these key areas. Together, we will discuss how to more effectively bridge the gap between bench-to-bedside research and clinical practice, looking forward to new directions in individualized prevention and care.

This is an academic exchange focused on the frontier of innovation. We look forward to your participation and hope that through in-depth dialogue, we can further promote the clinical application of personalized medicine in the field of neurodevelopment, contributing to the advancement of precision healthcare for ASD.”Welcome to this Journal of Personalized Medicine webinar. It is my great pleasure to serve as the Chair for today’s webinar.

We are currently in an era of rapid development in precision medicine. The traditional ‘one-size-fits-all’ approach to neurodevelopmental disorders is being replaced by personalized strategies tailored to the unique biological and genetic profiles of each individual. Autism Spectrum Disorder, characterized by its high degree of clinical and genetic heterogeneity, stands as one of the most critical frontiers for this transition.

As we move beyond broad behavioral diagnoses, the integration of multi-omics—including genomics, epigenetics, and metabolic profiling—is profoundly transforming our understanding of ASD. By identifying specific biological subtypes and individualized disease mechanisms, we can move toward earlier detection and more targeted interventions. Whether through pharmacogenetics to optimize medication or personalized behavioral therapies guided by biomarkers, our ultimate goal is to ensure that every individual receives the most effective, life-enhancing support at the earliest possible stage.

For this webinar, we are honored to welcom several distinguished experts in this field, including clinical geneticists, neuroscientists, psychiatrists, and pediatricians. They will share the latest basic research findings, clinical translational results, and cutting-edge academic perspectives focused on these key areas. Together, we will discuss how to more effectively bridge the gap between bench-to-bedside research and clinical practice, looking forward to new directions in individualized prevention and care.

This is an academic exchange focused on the frontier of innovation. We look forward to your participation and hope that through in-depth dialogue, we can further promote the clinical application of personalized medicine in the field of neurodevelopment, contributing to the advancement of precision healthcare for ASD.

Date: June 24th, 2026
Time: 5:00pm CEST | 11:00am EDT
Zoom ID: 815 6168 6039
Webinar Secretariat: journal.webinar@mdpi.com